Why the study?
Does rectally administered midazolam improve premedication efficacy and sedation in ASA grade I and II children aged 5-10 years?
Does rectally administered midazolam improve premedication efficacy and sedation in ASA grade I and II children aged 5-10 years?
Rectal midazolam at 0.3 mg/kg is an effective premedication for children that provides satisfactory sedation and smooth emergence from anesthesia, though it may delay recovery.
Answers are grounded in this paper and cite their sources.
Supports rectal midazolam 0.3 mg/kg for pediatric premedication with stable parameters; confirms non-IV route efficacy but flags recovery delay.
This prospective double blind and randomized study was undertaken to evaluate the efficacy of rectally administered midazolam for premedication of paediatric patients. 100 ASA grade I and II children in the age group of 5-10 years were randomly allocated to two groups of 50 patients each. Group I (midazolam group) received 0.3mg/kg midazolam rectally and group II (saline group) received 5 ml of normal saline rectally.The results of the study showed that midazolam in the dosage of 0.3mg/kg given rectally was acceptable to children, produced satisfactory sedation, provided easy separation of children from parents, maintained stable cardio respiratory status preoperatively as well as postoperatively and produced smooth emergence from anaesthesia but with delayed recovery.
No takes yet. Share an insight, caveat, or question.
A 2009 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: